Rothblatt Martine A 的 Form 4 申報
United Therapeutics Corp（UTHR），2025/10/16 申報
- 申報編號
- 0001106578-25-000020
- 申報時間
- 2025/10/16
- 交易日
- 2025/10/15-10/16
- 申報延遲
- 1 天
- 10b5-1 計畫
- 有勾選
這份申報列了 8 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $346.6 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Rothblatt Martine ACIK 0001106578 | 董事、高階主管（董事長、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/10/15 | Common Stock | M行使選擇權取得 | +4,000 | $120.26 | +$481,040 | 4,130 | 直接 | |
| 2025/10/15 | Common Stock | S賣出處分 | −1,000 | $433.42 | −$433,420 | 3,130 | 直接 | |
| 2025/10/15 | Common Stock | S賣出處分 | −1,000 | $434.80 | −$434,800 | 2,130 | 直接 | |
| 2025/10/15 | Common Stock | S賣出處分 | −2,000 | $436.47F2 | −$872,940 | 130 | 直接 | |
| 2025/10/16 | Common Stock | M行使選擇權取得 | +4,000 | $120.26 | +$481,040 | 4,130 | 直接 | |
| 2025/10/16 | Common Stock | S賣出處分 | −1,500 | $430.23F3 | −$645,345 | 2,630 | 直接 | |
| 2025/10/16 | Common Stock | S賣出處分 | −1,654 | $431.51F4 | −$713,717.54 | 976 | 直接 | |
| 2025/10/16 | Common Stock | S賣出處分 | −846 | $432.86 | −$366,199.56 | 130 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/10/15 | Common Stock | M行使選擇權處分 | −4,000 | $0.00 | $0 | 182,000 | 直接 | |
| 2025/10/16 | Common Stock | M行使選擇權處分 | −4,000 | $0.00 | $0 | 178,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $436.01 to $436.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $430.13 to $430.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $431.29 to $431.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。